DUB3	B:C1451084
and	O
USP7	O
de-ubiquitinating	O
enzymes	I:C1333282
control	O
replication	O
inhibitor	I:C1325319
Geminin	O
:	O
molecular	O
characterization	O
and	O
associations	O
with	O
breast	O
cancer	I:C0006142
.	O

DUB3	O
and	O
USP7	B:C1142946
de-ubiquitinating	O
enzymes	I:C1333282
control	O
replication	O
inhibitor	I:C1325319
Geminin	O
:	O
molecular	O
characterization	O
and	O
associations	O
with	O
breast	O
cancer	I:C0006142
.	O

DUB3	O
and	O
USP7	O
de-ubiquitinating	B:C1333282
enzymes	I:C1333282
control	O
replication	O
inhibitor	I:C1325319
Geminin	O
:	O
molecular	O
characterization	O
and	O
associations	O
with	O
breast	O
cancer	I:C0006142
.	O

DUB3	O
and	O
USP7	O
de-ubiquitinating	O
enzymes	I:C1333282
control	O
replication	B:C1325319
inhibitor	I:C1325319
Geminin	O
:	O
molecular	O
characterization	O
and	O
associations	O
with	O
breast	O
cancer	I:C0006142
.	O

DUB3	O
and	O
USP7	O
de-ubiquitinating	O
enzymes	I:C1333282
control	O
replication	O
inhibitor	I:C1325319
Geminin	B:C3665616
:	O
molecular	O
characterization	O
and	O
associations	O
with	O
breast	O
cancer	I:C0006142
.	O

DUB3	O
and	O
USP7	O
de-ubiquitinating	O
enzymes	I:C1333282
control	O
replication	O
inhibitor	I:C1325319
Geminin	O
:	O
molecular	O
characterization	O
and	O
associations	O
with	O
breast	B:C0006142
cancer	I:C0006142
.	O

Correct	O
control	B:C1155665
of	I:C1155665
DNA	I:C1155665
replication	I:C1155665
is	O
crucial	O
to	O
maintain	O
genomic	O
stability	I:C1257825
in	O
dividing	O
cells	I:C0230517
.	O

Correct	O
control	O
of	I:C1155665
DNA	I:C1155665
replication	I:C1155665
is	O
crucial	O
to	O
maintain	O
genomic	B:C1257825
stability	I:C1257825
in	O
dividing	O
cells	I:C0230517
.	O

Correct	O
control	O
of	I:C1155665
DNA	I:C1155665
replication	I:C1155665
is	O
crucial	O
to	O
maintain	O
genomic	O
stability	I:C1257825
in	O
dividing	B:C0230517
cells	I:C0230517
.	O

Inappropriate	O
re-licensing	O
of	O
replicated	B:C0242961
origins	I:C0242961
is	O
associated	O
with	O
chromosomal	O
instability	I:C1257806
(	O
chromosomal	O
instability	I:C1257806
)	O
,	O
a	O
hallmark	O
of	O
cancer	O
progression	I:C1947901
that	O
at	O
the	O
same	O
time	O
provides	O
potential	O
opportunities	O
for	O
therapeutic	O
intervention	I:C0808232
.	O

Inappropriate	O
re-licensing	O
of	O
replicated	O
origins	I:C0242961
is	O
associated	O
with	O
chromosomal	B:C1257806
instability	I:C1257806
(	O
chromosomal	O
instability	I:C1257806
)	O
,	O
a	O
hallmark	O
of	O
cancer	O
progression	I:C1947901
that	O
at	O
the	O
same	O
time	O
provides	O
potential	O
opportunities	O
for	O
therapeutic	O
intervention	I:C0808232
.	O

Inappropriate	O
re-licensing	O
of	O
replicated	O
origins	I:C0242961
is	O
associated	O
with	O
chromosomal	O
instability	I:C1257806
(	O
chromosomal	B:C1257806
instability	I:C1257806
)	O
,	O
a	O
hallmark	O
of	O
cancer	O
progression	I:C1947901
that	O
at	O
the	O
same	O
time	O
provides	O
potential	O
opportunities	O
for	O
therapeutic	O
intervention	I:C0808232
.	O

Inappropriate	O
re-licensing	O
of	O
replicated	O
origins	I:C0242961
is	O
associated	O
with	O
chromosomal	O
instability	I:C1257806
(	O
chromosomal	O
instability	I:C1257806
)	O
,	O
a	O
hallmark	O
of	O
cancer	B:C1947901
progression	I:C1947901
that	O
at	O
the	O
same	O
time	O
provides	O
potential	O
opportunities	O
for	O
therapeutic	O
intervention	I:C0808232
.	O

Inappropriate	O
re-licensing	O
of	O
replicated	O
origins	I:C0242961
is	O
associated	O
with	O
chromosomal	O
instability	I:C1257806
(	O
chromosomal	O
instability	I:C1257806
)	O
,	O
a	O
hallmark	O
of	O
cancer	O
progression	I:C1947901
that	O
at	O
the	O
same	O
time	O
provides	O
potential	O
opportunities	O
for	O
therapeutic	B:C0808232
intervention	I:C0808232
.	O

Geminin	B:C3665616
is	O
a	O
critical	O
inhibitor	O
of	O
the	O
DNA	O
replication	I:C0598312
licensing	O
factor	I:C1334394
Cdt1	O
.	O

Geminin	O
is	O
a	O
critical	O
inhibitor	B:C0243077
of	O
the	O
DNA	O
replication	I:C0598312
licensing	O
factor	I:C1334394
Cdt1	O
.	O

Geminin	O
is	O
a	O
critical	O
inhibitor	O
of	O
the	O
DNA	B:C0598312
replication	I:C0598312
licensing	O
factor	I:C1334394
Cdt1	O
.	O

Geminin	O
is	O
a	O
critical	O
inhibitor	O
of	O
the	O
DNA	O
replication	I:C0598312
licensing	B:C1334394
factor	I:C1334394
Cdt1	O
.	O

Geminin	O
is	O
a	O
critical	O
inhibitor	O
of	O
the	O
DNA	O
replication	I:C0598312
licensing	O
factor	I:C1334394
Cdt1	B:C1332742
.	O

To	O
properly	O
achieve	O
its	O
functions	O
,	O
Geminin	B:C3665616
levels	O
are	O
tightly	O
regulated	O
through	O
the	O
cell	O
cycle	I:C0007586
by	O
ubiquitin	O
-	I:C1523807
dependent	I:C1523807
proteasomal	I:C1523807
degradation	I:C1523807
,	O
but	O
the	O
de-ubiquitinating	O
enzymes	I:C1333282
(	O
de-ubiquitinating	O
enzymes	I:C1333282
)	O
involved	O
had	O
not	O
been	O
identified	O
.	O

To	O
properly	O
achieve	O
its	O
functions	O
,	O
Geminin	O
levels	O
are	O
tightly	O
regulated	O
through	O
the	O
cell	B:C0007586
cycle	I:C0007586
by	O
ubiquitin	O
-	I:C1523807
dependent	I:C1523807
proteasomal	I:C1523807
degradation	I:C1523807
,	O
but	O
the	O
de-ubiquitinating	O
enzymes	I:C1333282
(	O
de-ubiquitinating	O
enzymes	I:C1333282
)	O
involved	O
had	O
not	O
been	O
identified	O
.	O

To	O
properly	O
achieve	O
its	O
functions	O
,	O
Geminin	O
levels	O
are	O
tightly	O
regulated	O
through	O
the	O
cell	O
cycle	I:C0007586
by	O
ubiquitin	B:C1523807
-	I:C1523807
dependent	I:C1523807
proteasomal	I:C1523807
degradation	I:C1523807
,	O
but	O
the	O
de-ubiquitinating	O
enzymes	I:C1333282
(	O
de-ubiquitinating	O
enzymes	I:C1333282
)	O
involved	O
had	O
not	O
been	O
identified	O
.	O

To	O
properly	O
achieve	O
its	O
functions	O
,	O
Geminin	O
levels	O
are	O
tightly	O
regulated	O
through	O
the	O
cell	O
cycle	I:C0007586
by	O
ubiquitin	O
-	I:C1523807
dependent	I:C1523807
proteasomal	I:C1523807
degradation	I:C1523807
,	O
but	O
the	O
de-ubiquitinating	B:C1333282
enzymes	I:C1333282
(	O
de-ubiquitinating	O
enzymes	I:C1333282
)	O
involved	O
had	O
not	O
been	O
identified	O
.	O

To	O
properly	O
achieve	O
its	O
functions	O
,	O
Geminin	O
levels	O
are	O
tightly	O
regulated	O
through	O
the	O
cell	O
cycle	I:C0007586
by	O
ubiquitin	O
-	I:C1523807
dependent	I:C1523807
proteasomal	I:C1523807
degradation	I:C1523807
,	O
but	O
the	O
de-ubiquitinating	O
enzymes	I:C1333282
(	O
de-ubiquitinating	B:C1333282
enzymes	I:C1333282
)	O
involved	O
had	O
not	O
been	O
identified	O
.	O

Here	O
we	O
report	O
that	O
DUB3	B:C1451084
and	O
USP7	O
control	O
human	O
Geminin	I:C0676272
.	O

Here	O
we	O
report	O
that	O
DUB3	O
and	O
USP7	B:C1142946
control	O
human	O
Geminin	I:C0676272
.	O

Here	O
we	O
report	O
that	O
DUB3	O
and	O
USP7	O
control	O
human	B:C0676272
Geminin	I:C0676272
.	O

Overexpression	B:C1514559
of	O
either	O
DUB3	O
or	O
USP7	O
increases	O
Geminin	O
levels	O
through	O
reduced	O
ubiquitination	O
.	O

Overexpression	O
of	O
either	O
DUB3	B:C1451084
or	O
USP7	O
increases	O
Geminin	O
levels	O
through	O
reduced	O
ubiquitination	O
.	O

Overexpression	O
of	O
either	O
DUB3	O
or	O
USP7	B:C1142946
increases	O
Geminin	O
levels	O
through	O
reduced	O
ubiquitination	O
.	O

Overexpression	O
of	O
either	O
DUB3	O
or	O
USP7	O
increases	O
Geminin	B:C3665616
levels	O
through	O
reduced	O
ubiquitination	O
.	O

Overexpression	O
of	O
either	O
DUB3	O
or	O
USP7	O
increases	O
Geminin	O
levels	O
through	O
reduced	O
ubiquitination	B:C1519751
.	O

Conversely	O
,	O
depletion	O
of	O
DUB3	B:C1451084
or	O
USP7	O
reduces	O
Geminin	O
levels	O
,	O
and	O
DUB3	O
knockdown	O
increases	O
re-replication	O
events	I:C1155651
,	O
analogous	O
to	O
the	O
effect	O
of	O
Geminin	O
depletion	O
.	O

Conversely	O
,	O
depletion	O
of	O
DUB3	O
or	O
USP7	B:C1142946
reduces	O
Geminin	O
levels	O
,	O
and	O
DUB3	O
knockdown	O
increases	O
re-replication	O
events	I:C1155651
,	O
analogous	O
to	O
the	O
effect	O
of	O
Geminin	O
depletion	O
.	O

Conversely	O
,	O
depletion	O
of	O
DUB3	O
or	O
USP7	O
reduces	O
Geminin	B:C3665616
levels	O
,	O
and	O
DUB3	O
knockdown	O
increases	O
re-replication	O
events	I:C1155651
,	O
analogous	O
to	O
the	O
effect	O
of	O
Geminin	O
depletion	O
.	O

Conversely	O
,	O
depletion	O
of	O
DUB3	O
or	O
USP7	O
reduces	O
Geminin	O
levels	O
,	O
and	O
DUB3	B:C1857782
knockdown	O
increases	O
re-replication	O
events	I:C1155651
,	O
analogous	O
to	O
the	O
effect	O
of	O
Geminin	O
depletion	O
.	O

Conversely	O
,	O
depletion	O
of	O
DUB3	O
or	O
USP7	O
reduces	O
Geminin	O
levels	O
,	O
and	O
DUB3	O
knockdown	B:C2350567
increases	O
re-replication	O
events	I:C1155651
,	O
analogous	O
to	O
the	O
effect	O
of	O
Geminin	O
depletion	O
.	O

Conversely	O
,	O
depletion	O
of	O
DUB3	O
or	O
USP7	O
reduces	O
Geminin	O
levels	O
,	O
and	O
DUB3	O
knockdown	O
increases	O
re-replication	B:C1155651
events	I:C1155651
,	O
analogous	O
to	O
the	O
effect	O
of	O
Geminin	O
depletion	O
.	O

Conversely	O
,	O
depletion	O
of	O
DUB3	O
or	O
USP7	O
reduces	O
Geminin	O
levels	O
,	O
and	O
DUB3	O
knockdown	O
increases	O
re-replication	O
events	I:C1155651
,	O
analogous	O
to	O
the	O
effect	O
of	O
Geminin	B:C3665616
depletion	O
.	O

In	O
exploring	O
potential	O
clinical	O
implications	O
,	O
we	O
found	O
that	O
USP7	B:C1142946
and	O
Geminin	O
are	O
strongly	O
correlated	O
in	O
a	O
cohort	O
of	O
invasive	O
breast	O
cancers	I:C0006142
(	O
P<	O
1.01E	O
-	O
08	O
)	O
.	O

In	O
exploring	O
potential	O
clinical	O
implications	O
,	O
we	O
found	O
that	O
USP7	O
and	O
Geminin	B:C3665616
are	O
strongly	O
correlated	O
in	O
a	O
cohort	O
of	O
invasive	O
breast	O
cancers	I:C0006142
(	O
P<	O
1.01E	O
-	O
08	O
)	O
.	O

In	O
exploring	O
potential	O
clinical	O
implications	O
,	O
we	O
found	O
that	O
USP7	O
and	O
Geminin	O
are	O
strongly	O
correlated	O
in	O
a	O
cohort	B:C0599755
of	O
invasive	O
breast	O
cancers	I:C0006142
(	O
P<	O
1.01E	O
-	O
08	O
)	O
.	O

In	O
exploring	O
potential	O
clinical	O
implications	O
,	O
we	O
found	O
that	O
USP7	O
and	O
Geminin	O
are	O
strongly	O
correlated	O
in	O
a	O
cohort	O
of	O
invasive	O
breast	B:C0006142
cancers	I:C0006142
(	O
P<	O
1.01E	O
-	O
08	O
)	O
.	O

As	O
expected	O
,	O
Geminin	B:C3665616
expression	O
is	O
highly	O
prognostic	O
.	O

As	O
expected	O
,	O
Geminin	O
expression	B:C1171362
is	O
highly	O
prognostic	O
.	O

Interestingly	O
,	O
we	O
found	O
a	O
non-monotonic	O
relationship	O
between	O
USP7	B:C1142946
and	O
breast	O
cancer	I:C0006142
-	O
specific	O
survival	O
,	O
with	O
both	O
very	O
low	O
or	O
high	O
levels	O
of	O
USP7	O
associated	O
with	O
poor	O
outcome	I:C3806166
,	O
independent	O
of	O
estrogen	O
receptor	I:C0034804
status	O
.	O

Interestingly	O
,	O
we	O
found	O
a	O
non-monotonic	O
relationship	O
between	O
USP7	O
and	O
breast	B:C0006142
cancer	I:C0006142
-	O
specific	O
survival	O
,	O
with	O
both	O
very	O
low	O
or	O
high	O
levels	O
of	O
USP7	O
associated	O
with	O
poor	O
outcome	I:C3806166
,	O
independent	O
of	O
estrogen	O
receptor	I:C0034804
status	O
.	O

Interestingly	O
,	O
we	O
found	O
a	O
non-monotonic	O
relationship	O
between	O
USP7	O
and	O
breast	O
cancer	I:C0006142
-	O
specific	O
survival	O
,	O
with	O
both	O
very	O
low	O
or	O
high	O
levels	O
of	O
USP7	B:C1142946
associated	O
with	O
poor	O
outcome	I:C3806166
,	O
independent	O
of	O
estrogen	O
receptor	I:C0034804
status	O
.	O

Interestingly	O
,	O
we	O
found	O
a	O
non-monotonic	O
relationship	O
between	O
USP7	O
and	O
breast	O
cancer	I:C0006142
-	O
specific	O
survival	O
,	O
with	O
both	O
very	O
low	O
or	O
high	O
levels	O
of	O
USP7	O
associated	O
with	O
poor	B:C3806166
outcome	I:C3806166
,	O
independent	O
of	O
estrogen	O
receptor	I:C0034804
status	O
.	O

Interestingly	O
,	O
we	O
found	O
a	O
non-monotonic	O
relationship	O
between	O
USP7	O
and	O
breast	O
cancer	I:C0006142
-	O
specific	O
survival	O
,	O
with	O
both	O
very	O
low	O
or	O
high	O
levels	O
of	O
USP7	O
associated	O
with	O
poor	O
outcome	I:C3806166
,	O
independent	O
of	O
estrogen	B:C0034804
receptor	I:C0034804
status	O
.	O

Altogether	O
,	O
our	O
data	O
identify	O
DUB3	B:C1451084
and	O
USP7	O
as	O
factors	O
that	O
regulate	O
DNA	I:C1155665
replication	I:C1155665
by	O
controlling	O
Geminin	O
protein	O
stability	O
,	O
and	O
suggest	O
that	O
USP7	O
may	O
be	O
involved	O
in	O
Geminin	O
dysregulation	O
during	O
breast	O
cancer	I:C0006142
progression	O
.	O

Altogether	O
,	O
our	O
data	O
identify	O
DUB3	O
and	O
USP7	B:C1142946
as	O
factors	O
that	O
regulate	O
DNA	I:C1155665
replication	I:C1155665
by	O
controlling	O
Geminin	O
protein	O
stability	O
,	O
and	O
suggest	O
that	O
USP7	O
may	O
be	O
involved	O
in	O
Geminin	O
dysregulation	O
during	O
breast	O
cancer	I:C0006142
progression	O
.	O

Altogether	O
,	O
our	O
data	O
identify	O
DUB3	O
and	O
USP7	O
as	O
factors	O
that	O
regulate	B:C1155665
DNA	I:C1155665
replication	I:C1155665
by	O
controlling	O
Geminin	O
protein	O
stability	O
,	O
and	O
suggest	O
that	O
USP7	O
may	O
be	O
involved	O
in	O
Geminin	O
dysregulation	O
during	O
breast	O
cancer	I:C0006142
progression	O
.	O

Altogether	O
,	O
our	O
data	O
identify	O
DUB3	O
and	O
USP7	O
as	O
factors	O
that	O
regulate	O
DNA	I:C1155665
replication	I:C1155665
by	O
controlling	O
Geminin	B:C3665616
protein	O
stability	O
,	O
and	O
suggest	O
that	O
USP7	O
may	O
be	O
involved	O
in	O
Geminin	O
dysregulation	O
during	O
breast	O
cancer	I:C0006142
progression	O
.	O

Altogether	O
,	O
our	O
data	O
identify	O
DUB3	O
and	O
USP7	O
as	O
factors	O
that	O
regulate	O
DNA	I:C1155665
replication	I:C1155665
by	O
controlling	O
Geminin	O
protein	O
stability	O
,	O
and	O
suggest	O
that	O
USP7	B:C1142946
may	O
be	O
involved	O
in	O
Geminin	O
dysregulation	O
during	O
breast	O
cancer	I:C0006142
progression	O
.	O

Altogether	O
,	O
our	O
data	O
identify	O
DUB3	O
and	O
USP7	O
as	O
factors	O
that	O
regulate	O
DNA	I:C1155665
replication	I:C1155665
by	O
controlling	O
Geminin	O
protein	O
stability	O
,	O
and	O
suggest	O
that	O
USP7	O
may	O
be	O
involved	O
in	O
Geminin	B:C3665616
dysregulation	O
during	O
breast	O
cancer	I:C0006142
progression	O
.	O

Altogether	O
,	O
our	O
data	O
identify	O
DUB3	O
and	O
USP7	O
as	O
factors	O
that	O
regulate	O
DNA	I:C1155665
replication	I:C1155665
by	O
controlling	O
Geminin	O
protein	O
stability	O
,	O
and	O
suggest	O
that	O
USP7	O
may	O
be	O
involved	O
in	O
Geminin	O
dysregulation	B:C1704258
during	O
breast	O
cancer	I:C0006142
progression	O
.	O

Altogether	O
,	O
our	O
data	O
identify	O
DUB3	O
and	O
USP7	O
as	O
factors	O
that	O
regulate	O
DNA	I:C1155665
replication	I:C1155665
by	O
controlling	O
Geminin	O
protein	O
stability	O
,	O
and	O
suggest	O
that	O
USP7	O
may	O
be	O
involved	O
in	O
Geminin	O
dysregulation	O
during	O
breast	B:C0006142
cancer	I:C0006142
progression	O
.	O

Altogether	O
,	O
our	O
data	O
identify	O
DUB3	O
and	O
USP7	O
as	O
factors	O
that	O
regulate	O
DNA	I:C1155665
replication	I:C1155665
by	O
controlling	O
Geminin	O
protein	O
stability	O
,	O
and	O
suggest	O
that	O
USP7	O
may	O
be	O
involved	O
in	O
Geminin	O
dysregulation	O
during	O
breast	O
cancer	I:C0006142
progression	B:C1947901
.	O

